TELA Bio Announces Closing of Public Offering of Common Stock
MALVERN, Pa., June 30, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, […]
Exela Technologies, Inc. Reports First Quarter 2020 Results
Files Form 10-Q for the Three Months Ended March 31, 2020Conference Call to Discuss Results Scheduled for June 30, 2020 […]
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the […]
Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR
New Guidelines Consistent with Silk Road Medical Certification ProcessSUNNYVALE, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: […]
Aravive Added to the Russell 2000® and Russell 3000® Indexes
HOUSTON, June 30, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the […]
Akouos Announces Closing of Initial Public Offering
BOSTON, June 30, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing […]
Amdocs Chosen by Three to Support its Enterprise Business in the UK in Multi-Year Deal
ST. LOUIS, June 30, 2020 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications […]
T2 Biosystems Announces Preliminary Second Quarter 2020 Financial Results
LEXINGTON, Mass., June 30, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing […]
CrossFirst Announces Details of Second Quarter 2020 Earnings Release, Webcast and Conference Call
LEAWOOD, Kan., June 30, 2020 (GLOBE NEWSWIRE) — CrossFirst Bankshares, Inc. (Nasdaq: CFB) will release its second quarter 2020 results […]
Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical […]
